Psychometric Rater Stress and Burnout
Salt Lake City, Utah, May 29, 2024 (GLOBE NEWSWIRE) — Poster presented today at American Society of Clinical Pharmacology (ASCP) Annual Meeting in Miami Beach, Florida, shows: High levels of
View More Revisiting the Ketamine ‘Model’ for Schizophrenia
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Download the full poster as a PDF. [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
View More Validation of a suite of ERP and QEEG biomarkers
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers Written by: M. Cecchi a,*, M. Adachi
View More Electrophysiology Based Biomarkers as Outcome Measures
Electrophysiology Based Biomarkers as Outcome Measures, Demonstrate Signal Detection and Reliability in a Simulated Clinical Trial at an Experienced Clinical Research Center Evaluating Study Drug (Ketamine) and Placebo Larry
View More
Training on the Placebo-Control Reminder Script
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]CenExel is proud to highlight the poster we’re presenting
View More The Placebo-Control Reminder Script and Supplementary Instrument Properties
CenExel is proud to highlight the poster presented at the International Society for CNS Clinical Trials and Methodology (ISCTM) Annual Scientific Meeting, February 2023, Washington, DC. ABSTRACT Introduction: The
View More PCRS: Essential Perspectives from the End User
CenExel is proud to highlight the poster presented at the Annual CNS Summit, November 2022, Boca Raton, FL. ABSTRACT Introduction: Placebo and nocebo responses continue to hinder potential treatment
View More Enhancing Patient Retention in ADHD studies
CenExel is proud to highlight the poster presented at the Annual Meeting of the American Society of Clinical Psychopharmacology (ASCP), May 2022, Scottsdale, AZ. ABSTRACT Introduction: Reducing study participant
View More Retention in Schizophrenia and Schizoaffective Disorder Studies
CenExel is proud to highlight the poster presented at the Schizophrenia International Research Society (SIRS) Annual Scientific Meeting, April 2022, Florence Italy. ABSTRACT Background: Clinical trials focusing on psychosis
View More Participant Retention in Depression Studies
CenExel is proud to highlight the poster presented at the International Society for CNS Clinical Trials and Methodology (ISCTM) Annual Scientific Meeting, February 2022, Washington, DC. ABSTRACT Introduction: It
View More
